1	Canagliflozina	canagliflozina	NCFS000	-	-	0-14	436(2)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
2	(	(	Fpa	-	-	15-16	436(2)_ANS_clinical_caseMIR	SENT1	-	-
3	inhibidor	inhibidor	NCMS000	-	-	16-25	436(2)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
4	del	del	SP+DA	-	-	26-29	436(2)_ANS_clinical_caseMIR	SENT1	-	-
5	cotransportador	cotransportador	NCMS000	-	-	30-45	436(2)_ANS_clinical_caseMIR	SENT1	-	-
6	2	2		-	-	46-47	436(2)_ANS_clinical_caseMIR	SENT1	-	-
7	de	de	SPS00	C0332285	atributo	48-50	436(2)_ANS_clinical_caseMIR	SENT1	-	-
8	sodio-glucosa	sodio-glucosa	NCFS000	-	-	51-64	436(2)_ANS_clinical_caseMIR	SENT1	-	-
9	-	-	Fg	-	-	64-65	436(2)_ANS_clinical_caseMIR	SENT1	-	-
10	iSGLT2	iSGLT2		-	-	66-72	436(2)_ANS_clinical_caseMIR	SENT1	-	-
11	)	)	Fpt	-	-	72-73	436(2)_ANS_clinical_caseMIR	SENT1	-	-
12	.	.	Fp	-	-	74-75	436(2)_ANS_clinical_caseMIR	SENT1	-	-

